Timothy J. Smith
Investor Relations Contact bei PMV PHARMACEUTICALS, INC.
Profil
Timothy J.
Smith is currently the Senior Vice President & Head-Corporate Development at Celgene Corp.
and the Head-Corporate Development & Investor Relations at PMV Pharmaceuticals, Inc. Previously, he held the position of Executive Director-Global Business Planning at Celgene Corp.
from 2013 to 2016.
He also worked as the Senior Director-Investor Relations at MGI PHARMA, Inc., Chief Business Officer at Cleave Therapeutics, Inc., and Chief Business Officer at Verseau Therapeutics, Inc. Mr. Smith has a graduate degree from The Trustees of Columbia University in The City of New York, an MBA from Fordham University, and an undergraduate degree from The University of Texas at Austin.
Aktive Positionen von Timothy J. Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 09.09.2021 |
| PMV PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Timothy J. Smith
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Investor Relations Contact | 03.01.2012 |
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Corporate Officer/Principal | - |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Investor Relations Contact | - |
Ausbildung von Timothy J. Smith
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Fordham University | Masters Business Admin |
| The University of Texas at Austin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Commercial Services |
